XML 35 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating expenses:    
Research and development $ 21,533 $ 18,736
General and administrative 5,292 5,145
Total operating expenses 26,825 23,881
Loss from operations (26,825) (23,881)
Other income (expense):    
Interest income 183 1,187
Change in fair value of the tranche rights 0 (4,796)
Other income (expense), net 1,169 (2,094)
Total other income (expense) 1,352 (5,703)
Net loss $ (25,473) $ (29,584)
Net loss per share, basic (in usd per share) $ (0.25) $ (0.30)
Net loss per share, diluted (in usd per share) $ (0.25) $ (0.30)
Weighted-average common shares outstanding, basic (in shares) 101,344,433 97,299,955
Weighted-average common shares outstanding, diluted (in shares) 101,344,433 97,299,955